Report Description

United Kingdom precision medicine market is expected to register robust growth in the forecast period, 2023-2027. Precision medicine evaluates the genes and proteins which are present in the body of a patient to design the personalized treatment drug to cure the specific disease. With such discoveries including single nucleotide polymorphism and microarray/ biochips in the field of precision medicine, the market is projected to experience a boom in the upcoming years. Continuous research activities on human genome are the future of precision medicine and has a potential to upend the medical treatment on individual patients by understanding their genetics, molecular profiles, and clinical characteristics. The growing prevalence of cancer is further escalating the demand for precision medicine for personalized therapeutics and diagnostics which is positively influence the growth of the market.

Growing Prevalence of CNS Disorders is Projected to Augment the Market Growth

CNS ailments include Alzheimer’s disease, multiple sclerosis, epilepsy, afflict millions of individuals across the globe which is primarily driving the market growth. Dementia affects more than 50 million individuals worldwide. Alzheimer's disease, the most common kind of dementia, accounts for 60-70 percent of all cases. The growth of the industry is aided by an enhancing focus on targeted therapeutics and the development of individualized medical treatment regimens for persons suffering from CNS illnesses.

Elevating Prevalence of Cancer Across the United Kingdom Drives the Market Growth

The escalating demand for precision medicine methods across the developed countries like UK owing to the rising prevalence of cancer and the increasing number of treatment candidates in clinical trials. This, turn, is driving the market growth. In addition to this, the rising number of cases of genetic diseases will continue to influence positively the growth of precision medicine market. With this, the elevating levels of urbanization and inflating level of disposable income are accelerating the growth of the precision medicine market. The growing expenditure on healthcare infrastructure and expanding geriatric population are the major market drivers that support the growth of precision medicine market. The recent development in technologies including the ultra-high throughout sequencing and next-generation sequencing is expected to fuel the growth of the market over the future years.

Extensive R&D Activities is Anticipated to Bolster the Market Growth

The growing number of research and development activities offer lucrative opportunities for the precision medicine market growth. The enhancing focus of manufacturers on the adoption of upgraded technologies and rise in the number of emerging economies will opportunities for the precision medicine market growth in the upcoming years.